ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS
biospace
January 02, 2018Nerviano (Milano), December 27, 2017 - SARI, a Chinese market-leader biotech investment company, today announced it has entered into an agreement to acquire the 90% interests in Group NMS? -
Native mass spectrometry uesed to help drug discovery
europeanpharmaceuticalreview
August 18, 2017Mass spectrometry (MS) performed under native-like conditions (nMS) is a promising approach for studying protein-drug interactions, and has already informed treatments of some of the most intractable diseases including cancer, diabetes and Alzheimer’s.
Pharma Sources Insight January 2025
